marijuana stocks news

Form 8-K for ENERTOPIA CORP.


19-Sep-2016

Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial State

Item 3.02 Unregistered Sales of Equity SecuritiesOn September 19, 2016, the Company entered into a one year Investor Relations Consulting agreement with Duncan McKay. Based on the terms of the agreement, Mr. McKay can earn up to a maximum of 10% commissions on capital raised. The Company issued 800,000 stock options with an exercise price of $0.07.

The Company issued 800,000 stock options. On July 15, 2014, the Company had adopted the 2014 Stock Option Plan. Based on this original Stock Option Plan, on September 19, 2016, the Company has granted 80,000 stock options to Duncan McKay. The exercise price of the stock options is $0.07, vested immediately, expiring September 19, 2021.

Name and Position Amount of stock options grant Duncan McKay 800,000

 

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the agreement and options grant is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No.                             Description

   10.1       Form of Stock Option Agreement
   10.2       Investor Relations Consulting Agreement dated September 19, 2016
   99.1       Press Release dated September 19, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reliq Health Technologies Inc. (RQHTF) Announces $7,500,000 Brokered Private Placement

Reliq Health Technologies Announces $7,500,000 Brokered Private Placement Co-led by Canaccord Genuity…

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGODF) Acquisition Announce Execution of Arrangement Agreement

The Green Organic Dutchman and TGOD Acquisition Announce Execution of Arrangement Agreement…

Canopy Growth Corporation (CGC) to Report Fourth Quarter and Fiscal Year 2022 Financial Results on May 27, 2022

Canopy Growth to Report Fourth Quarter and Fiscal Year 2022 Financial Results…

$NVLX Gets Exclusive Worldwide License To Use Unique Combine Cell-in-a-Box(R) and Cannabinoid-Based Medicine For Treatment Development

Nuvilex Obtains Exclusive Worldwide License to Develop Disease Treatments That Combine Cell-in-a-Box(R)…